Market closed
Elicio Therapeutics Inc./$ELTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
Ticker
$ELTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
32
Website
ELTX Metrics
BasicAdvanced
$83M
-
-$4.25
-
-
Price and volume
Market cap
$83M
52-week high
$8.84
52-week low
$4.75
Financial strength
Current ratio
1.796
Quick ratio
1.529
Long term debt to equity
-222.233
Total debt to equity
-230.198
Interest coverage (TTM)
-98.87%
Management effectiveness
Return on assets (TTM)
-101.64%
Return on equity (TTM)
-170,157.38%
Valuation
Price to book
-5.06
Price to tangible book (TTM)
-5.06
Price to free cash flow (TTM)
-1.705
Growth
Earnings per share change (TTM)
-38.90%
3-year earnings per share growth (CAGR)
35.02%
ELTX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Elicio Therapeutics Inc. stock?
Elicio Therapeutics Inc. (ELTX) has a market cap of $83M as of April 09, 2025.
What is the P/E ratio for Elicio Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Elicio Therapeutics Inc. (ELTX) stock is 0 as of April 09, 2025.
Does Elicio Therapeutics Inc. stock pay dividends?
No, Elicio Therapeutics Inc. (ELTX) stock does not pay dividends to its shareholders as of April 09, 2025.
When is the next Elicio Therapeutics Inc. dividend payment date?
Elicio Therapeutics Inc. (ELTX) stock does not pay dividends to its shareholders.
What is the beta indicator for Elicio Therapeutics Inc.?
Elicio Therapeutics Inc. (ELTX) does not currently have a Beta indicator.
